ImaRx Therapeutics, Inc.

ImaRx Therapeutics, Inc.

ImaRx Therapeutics, Inc. company was founded in 1999. ImaRx Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the development of therapies for stroke and other vascular disorders, using its microbubble technology. Its lead program, SonoLysis, involves the administration of its MRX-801 microspheres and ultrasound to break up blood clots and restore blood flow to oxygen deprived tissues. The MRX-801 microspheres are a proprietary formulation of a lipid shell encapsulating an inert biocompatible gas. Discontinued operations In September 2008, the company divested its urokinase business to Microbix.

Contact Details

Office Address

ImaRx Therapeutics, Inc.
P.O. Box 968
Round Rock, TX, USA 78680
Phone: (520) 548-0062


Chairman & Principal Exec. Officer

Mr. Richard L. Love

VP of Operations

Dr. Reena Zutshi

Business Reviews for ImaRx Therapeutics, Inc.

Related Companies